Luke Lavis has spent years developing fluorescent dyes in every color of the rainbow. The super-bright, long-lasting dyes have been used in labs around the world and have helped make Nobel Prize-winning microscopy advances ...
Aug 1, 2019
0
164
Nearly 13% of women born in the U.S. today will develop breast cancer at some point during their lives. Treatment for early-stage disease often includes breast-conserving surgery, where the tumor and some surrounding healthy ...
May 17, 2022
0
14
Research presented at SNM's 58th Annual Meeting may mark the expansion of a novel imaging agent for an optical technique called near-infrared fluorescence (NIRF), which uses light energy to glean information about cells and ...
Jun 6, 2011
0
0
A new tool developed at the Howard Hughes Medical Institute's Janelia Research Campus lets scientists shine a light on an animal's brain to permanently mark neurons that are active at a particular time. The tool—a fluorescent ...
Feb 12, 2015
0
93
A small molecule called VIP, known to synchronize time-keeping neurons in the brain's biological clock, has the startling effect of desynchronizing them at higher dosages, says a research team at Washington University in ...
Oct 28, 2013
0
0
Scientists have created cells with fluorescent dyes that change color in response to specific neurochemicals. By implanting these cells into living mammalian brains, they have shown how neurochemical signaling changes as ...
Oct 26, 2014
0
0
In a paper published Tuesday in the journal eLife, Michael Francis, PhD, and colleagues highlight a new role for the protein NRX-1, a synaptic organizer in the nervous system of the nematode C. elegans.
Jul 30, 2018
0
39
Getting vaccines to people who need them isn't always easy. Many vaccines require cold storage, making it difficult to ship them to remote areas that don't have the necessary infrastructure.
Apr 24, 2023
0
37
Take two cancer cells and compare their genomes. Surprisingly, they can be quite different. This genetic variation is one of the hallmarks of cancer, and one reason why treating cancer is so hard.
Feb 21, 2019
0
1
Ruxolitinib, a drug that is already approved by the U.S. Food and Drug Administration (FDA) for treating certain cancers and skin conditions, is effective at inhibiting CaMKII, a protein kinase linked to cardiac arrhythmias.
Jun 21, 2023
1
66
